The Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI 4) is a non-treatment clinical research study that seeks to discover, optimize, standardize, and validate clinical trial measures and biomarkers used in ongoing AD research. ADNI 4 is the latest phase of the initiative to provide researchers throughout the world access to ADNI data with the belief that open source is the best way to approach Alzheimer’s. In this historic study of brain aging, data from ADNI will help determine the best measures for diagnosis and disease monitoring, which will be used to accelerate the testing of therapeutic interventions and, ultimately, improve Alzheimer’s disease prevention and care.
Not Enrolling